Open AccessSuccessful treatment of giant basal cell carcinoma with topical imiquimod 5% cream with long term follow-up
Author(s) -
M Chun-Guang,
Qiman Liao,
ZH Yu-Yun,
CH Li-Hua,
Tiffany Cheng,
Han Jiande
Publication year - 2014
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.143520
Subject(s) - imiquimod , medicine , dermatology , basal cell carcinoma , basal cell , pathological , pathology
The use of the topical Imiquimod 5% cream offers a noninvasive, nonsurgical, and an effective option for the treatment of primary small (<2 cm) superficial basal cell carcinoma (sBCC). However, reports about successful treatment of giant (>5 cm) BCC with topical Imiquimod 5% cream are rare. We present our experience in the treatment of two giant tumors (6 × 8 cm(2), 5.2 × 4.2 cm(2)) of BCC on the face with Imiquimod 5% cream, 2 to 3 days/week for 12 weeks. Both the tumors were cured with clinical and pathological evidence, one with 6-year follow-up and the other with 3.5-year follow-up.